Humoral and mucosal immunity in protection from natural respiratory syncytial virus infection in adults

Journal of Infectious Diseases

Volumn 190, Issue 2, 2004, Pages 373-378

  Walsh, Edward E ^a   Falsey, Ann R ^b  

^a ROCHESTER GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; NEUTRALIZING ANTIBODY; VIRUS PROTEIN;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT MUCOSA; VIRUS INFECTION; VIRUS STRAIN;

ADULT; AGED; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; FEMALE; HUMANS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; NASAL MUCOSA; NEUTRALIZATION TESTS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; RISK FACTORS; VIRAL PROTEINS;

EID: 3242686716     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/421524     Document Type: Article

References (22)

1. Hall CB, McCarthy CA. Respiratory syncytial virus. In: Mandell G, Bennett J, Dolin R, eds. Mandell, Douglas and Bennett's principles and practice of infectious disease. New York: Churchill Livingstone, 1996: 1501-19.
2. Henderson FW, Collier AM, Clyde WA, Denny FW. Respiratory syncytial-virus infections, reinfections and immunity. N Engl J Med 1979; 300:530-4.
3. Falsey AR, Walsh EE. Respiratory syncytial virus infection in adults. Clin Microbiol Rev 2000; 13:371-84.
4. Englund JA, Piedra PA, Whimbey E. Prevention and treatment of respiratory syncytial virus and parainfluenza viruses in immunocompromised patients. Am J Med 1997; 102:61-70.
5. Walsh EE, Falsey AR, Hennessey PA. Respiratory syncytial virus and other infections in persons with chronic cardiopulmonary disease. Am J Respir Crit Care Med 1999; 160:791-5.
6. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289:179-86.
7. Han LL, Alexander JP, Anderson LJ. Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden. J Infect Dis 1999; 179:25-30.
8. Griffin MR, Coffey CS, Neuzil KM, Mitchel EF, Wright PF, Edwards K. Winter viruses: influenza and respiratory syncytial virus-related morbidity in chronic lung disease. Arch Intern Med 2002; 162:1229-36.
9. Falsey AR, Walsh EE. Humoral immunity to respiratory syncytial virus infection in the elderly. J Med Virol 1992; 36:39-43.
10. Walsh EE, Falsey AR. A simple and reproducible method for collecting nasal secretions from frail elderly adults for measurement of virus specific IgA. J Infect Dis 1999; 179:1268-73.
11. Walsh EE, Falsey AR, Swinburne IA, Formica MA. Reverse transcription polymerase chain reaction (RT-PCR) for diagnosis of respiratory syncytial virus infection in adults: use of a single-tube "hanging droplet" nested PCR. J Med Virol 2001; 63:259-63.
12. Falsey AR, Formica MA, Walsh EE. Diagnosis of respiratory syncytial virus infection: comparison of reverse transcription-PCR to viral culture and serology in adults with respiratory illness. J Clin Microbiol 2002; 40:817-20.
13. Falsey AR, Formica MA, Treanor JJ, Walsh EE. Comparison of quantitative reverse transcription-PCR to viral culture for assessment of respiratory syncytial virus shedding. J Clin Microbiol 2003; 41:4160-5.
14. Falsey AR, Cunningham CK, Barker WH, et al. Respiratory syncytial virus and influenza A infections in the hospitalized elderly. J Infect Dis 1995; 172:389-94.
15. Falsey AR, Walsh EE. Relationship of serum antibody to risk of respiratory syncytial virus infection in elderly adults. J Infect Dis 1998; 177:463-6.
16. Johnson PR, Olmsted RA, Prince GA, et al. Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity. J Virol 1987; 61:3163-6.
17. Walsh EE, Peterson DR, Falsey AR. Risk factors for severe respiratory syncytial virus infection in elderly adults. J Infect Dis 2004; 189:233-8.
18. Mills J, Van Kirk J, Wright PF, Chanock RM. Experimental respiratory syncytial virus infection of adults: possible mechanisms of resistance to infection and illness. J Immunol 1971; 107:123-30.
19. Watt PJ, Robinson BS, Pringle CR, Tyrrell DAJ. Determinants of susceptibility to challenge and the antibody response of adults volunteers given experimental respiratory syncytial virus vaccines. Vaccine 1990; 8: 231-6.
20. Hall CB, Walsh EE, Long CE, Schnabel KC. Immunity to and frequency of reinfection with respiratory syncytial virus. J Infect Dis 1991; 163: 693-8.
21. Levine S, Klaiber-Franco R, Paradiso P. Demonstration that glycoprotein G is the attachment protein of respiratory syncytial virus. J Gen Virol 1987; 68:2521-4.
22. Wright PF, Karron RA, Belshe RB, et al. Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy. J Infect Dis 2000; 182:1331-42.